跳到正文
原文
Medical Xpress·· 24 天前精选AI 评分73

高剂量缩宫素方案与产后出血率下降相关,阴道分娩相对降低约40%

High-dose oxytocin protocol linked to lower postpartum hemorrhage rates

AI 导读

密歇根大学医学院团队在 Obstetrics & Gynecology 发表的前后对照研究显示,将产后第一小时缩宫素剂量由标准方案的30单位提高到60单位后,产后出血率从14.3%降至11.2%。在2,674例分娩中,阴道分娩者相对下降约40%,剖宫产者未见统计学显著下降,研究还观察到总失血量和额外止血药物使用减少。作者表示结果值得关注,但尚需更多研究确认其在不同临床场景中的获益与安全性。

推荐理由

前后对照研究显示产后出血率由14.3%降至11.2%,为缩宫素剂量方案调整提供院内实施层面的参考。

正文
newborn
Credit: Pixabay/CC0 Public Domain

A change in how oxytocin is administered after childbirth may help reduce postpartum hemorrhage, a new study suggests.

The Michigan Medicine–led study in Obstetrics & Gynecology evaluated a quality improvement initiative that introduced a higher-dose oxytocin protocol during the third stage of labor.

Among 2,674 births reviewed at University of Michigan Health Von Voigtlander Women's Hospital, the rate of postpartum hemorrhage decreased significantly, driven by a reduction among patients with vaginal births.

"Our commitment to maternal health means continually evaluating our practices and looking for opportunities to strengthen the prevention and management of obstetric complications," said lead author Jourdan "Jourdie" Triebwasser, M.D., M.A., an obstetrician-gynecologist at U-M Health Von Voigtlander Women's Hospital and a researcher at Michigan Medicine.

"Our findings suggest that a simple change to a high-dose oxytocin protocol was associated with a meaningful reduction in postpartum hemorrhage."

A targeted change with measurable results

Postpartum hemorrhage is a leading cause of maternal illness and death. Although oxytocin is widely used to help the uterus contract and reduce bleeding after birth, the optimal dose and administration protocol continue to be studied.

The initiative described in the study increased the oxytocin dose administered to birthing women during the first hour after birth from 30 units under the hospital's standard protocol to 60 units under the updated protocol. Implementation included changes to medication orders and infusion pumps, along with staff education and training.

Researchers compared outcomes before and after implementation between Jan. 1 and July 6, 2024. The analysis found lower overall hemorrhage rates, with the greatest improvement among vaginal births, which experienced a relative reduction of approximately 40%. The overall rate of postpartum hemorrhage decreased from 14.3% before the protocol was introduced to 11.2% afterward.

Researchers also observed lower overall blood loss and reduced use of additional medications to help control bleeding.

The study did not find a statistically significant reduction in postpartum hemorrhage among patients who delivered by cesarean birth.

Additional research is needed, researchers say, to better understand the optimal oxytocin dose and its safety profile, particularly across different modes of delivery.

"These findings are promising, but further research is needed to confirm the benefits across clinical settings," Triebwasser said.

"Every opportunity to reduce preventable complications matters to patients and families, and we need to continue exploring evidence-based approaches to improving maternal outcomes."

Publication details

Jourdan E. Triebwasser et al., High-Dose Oxytocin Protocol Implementation and Postpartum Hemorrhage, Obstetrics & Gynecology (2026). DOI: 10.1097/aog.0000000000006351

Journal information: Obstetrics & Gynecology

Key medical concepts

Postpartum Hemorrhage

Who's behind this story?

Sadie Harley

Sadie Harley

BSc Life Sciences & Ecology. Microbiology lab background with pharmaceutical news experience in oil, gas, and renewable industries. Full profile →

Andrew Zinin

Andrew Zinin

Master's in physics with research experience. Long-time science news enthusiast. Plays key role in Science X's editorial success. Full profile →

Citation: High-dose oxytocin protocol linked to lower postpartum hemorrhage rates (2026, October 27) retrieved 27 October 2026 from https://medicalxpress.com/news/2026-10-high-dose-oxytocin-protocol-linked.html

This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.

来源:Medical Xpress · medicalxpress.com